CRP and atherosclerosis: This elevated risk is not merely coincidental but stems from shared inflammatory pathways, including those involving CRP, RANKL, and the receptor for advanced glycation end products (RAGE), linking persistent systemic inflammation with vascular dysfunction and atherosclerosis.